| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/12/2002 | EP1212366A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212359A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 06/12/2002 | EP1212346A1 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212340A1 29 human cancer associated proteins |
| 06/12/2002 | EP1212335A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 06/12/2002 | EP1212330A1 Androgen receptor modulator compounds and methods |
| 06/12/2002 | EP1212329A2 Amine derivatives of benzo[4,5]thieno[2,3-d]pyrimidine |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 06/12/2002 | EP1212325A2 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
| 06/12/2002 | EP1212323A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/12/2002 | EP1212322A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/12/2002 | EP1212318A1 Substituted indolinones as tyrosine kinase inhibitors |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212315A1 Novel chalcones |
| 06/12/2002 | EP1212312A1 Novel derivatives of flavones, xanthones and coumarins |
| 06/12/2002 | EP1212311A1 Chalcone coumarins |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212099A2 Amphiphilic prodrugs |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
| 06/12/2002 | EP1212068A1 Method of enhancing the efficacy of anti-tumor agents |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1212062A1 Use of thienopyrimidines |
| 06/12/2002 | EP1212057A1 Extended duration light activated cancer therapy |
| 06/12/2002 | EP1212052A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 06/12/2002 | EP1212041A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 06/12/2002 | EP1212040A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 06/12/2002 | EP1211931A1 A knockout mouse for the tumor suppressor gene anx7 |
| 06/12/2002 | EP1068192B1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 06/12/2002 | EP1039922B1 Improved interferon polymer conjugates |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0873312B1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/12/2002 | EP0873122B1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 06/12/2002 | EP0852467B1 Cancer chemoprotective food products |
| 06/12/2002 | EP0807185B1 Antitumor preparations containing a lipoteichoic acid from steptococcus |
| 06/12/2002 | EP0776324B1 Endothelin antagonists |
| 06/12/2002 | EP0751778B1 Use of deuterium-depleted water for preparing hygienic and cosmetic preparations |
| 06/12/2002 | EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 06/12/2002 | EP0737200B1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0689427B1 Water dispersible therapeutic carotenoid compounds |
| 06/12/2002 | EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
| 06/12/2002 | CN1353764A Method for selecting improved vectors |
| 06/12/2002 | CN1353717A Tetracyclic progesterone receptor modulator compounds and methods |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353694A Alpha-substituted carboxylic acid derivatives |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 06/12/2002 | CN1353183A Establishing recombinant strain of BCG vaccine and its application |
| 06/12/2002 | CN1352990A Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition |
| 06/12/2002 | CN1352987A Chinese medicine for treating leukemia |
| 06/12/2002 | CN1352986A Compound Wanqing capsule and its preparing process |
| 06/12/2002 | CN1352982A Enterior-applied Chinese medicine 'Shutonghuaaiping' for treating cerebroma and hydrocephalus |
| 06/12/2002 | CN1352977A Process for extracting anticancer product from natural plant |
| 06/12/2002 | CN1352973A Powdered medicine for treating tumor and its preparing process |
| 06/12/2002 | CN1352965A Medicine for treating cancers of esophagus, stomach and lung |
| 06/12/2002 | CN1352954A Disinfecting anticancer medicine |
| 06/12/2002 | CN1352953A Medicine for treating tumors (lung cancer) and its preparing process |
| 06/12/2002 | CN1352952A Prescription of Pugonglian Herbal medicine |
| 06/12/2002 | CN1352951A Prescription of Daolu powder |
| 06/12/2002 | CN1352944A Jixitabin solution preparation |
| 06/12/2002 | CN1352941A 亚油酸胶囊 Linoleic acid capsules |
| 06/12/2002 | CN1352940A Licopin linoleate capsule |
| 06/12/2002 | CN1352939A lycopene capsule |
| 06/12/2002 | CN1086188C Novel phenanethridinium derivatives |
| 06/12/2002 | CN1086132C Traditional Chinese medicinal pill for transforming calculus, eliminating toxin and antitumour |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403831 Substituted benzylidene indenyl formamides, acetamides and propionamides |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403656 Skin disorders |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403636 Xanthone compounds, their preparation and use as medicament |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403614 Such as 2-(4-(methylthiomethoxy)phenyl)-3-(4-(2-piperidin-1-yl)ethoxy) benzoyl)-6-methylthiomethoxybenzo(b)thiophene;inhibition of osteoporosis, hyperlipedemia, cancer, postmenopausal syndrome, |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403604 Nitrogen-based camptothecin derivatives |
| 06/11/2002 | US6403603 Antitumor agent |
| 06/11/2002 | US6403588 Imidazopyridine derivatives |
| 06/11/2002 | US6403569 Therapeutically synergistic, particularly colorectal cancer; campto? (cpt-11, irinotecan), and folinic acid |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |
| 06/11/2002 | US6403563 Antineoplastic topoisomerase i inhibitor |
| 06/11/2002 | US6403560 Extracting hyaluronic acid together with a protein from chicken comb, mammalian skin or mammalian organ; |
| 06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
| 06/11/2002 | US6403558 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |